[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 1846232}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.05, "open": 2.15, "dayLow": 2.0617, "dayHigh": 2.27, "regularMarketPreviousClose": 2.05, "regularMarketOpen": 2.15, "regularMarketDayLow": 2.0617, "regularMarketDayHigh": 2.27, "payoutRatio": 0.0, "beta": 0.294, "forwardPE": -3.8090909, "volume": 59635, "regularMarketVolume": 59635, "averageVolume": 60354, "averageVolume10days": 80620, "averageDailyVolume10Day": 80620, "bid": 1.53, "ask": 2.68, "bidSize": 2, "askSize": 2, "marketCap": 58077800, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 2.71, "fiftyDayAverage": 1.70606, "twoHundredDayAverage": 1.87351, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 41470632, "profitMargins": 0.0, "floatShares": 17986658, "sharesOutstanding": 27722100, "sharesShort": 191305, "sharesShortPriorMonth": 367356, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0069, "heldPercentInsiders": 0.39632, "heldPercentInstitutions": 0.12054, "shortRatio": 3.9, "shortPercentOfFloat": 0.0216, "impliedSharesOutstanding": 27722100, "bookValue": 0.481, "priceToBook": 4.3555093, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -21613376, "trailingEps": -0.76, "forwardEps": -0.55, "enterpriseToEbitda": -1.832, "52WeekChange": -0.10085839, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 2.095, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 17681954, "totalCashPerShare": 0.638, "ebitda": -22641740, "totalDebt": 1074770, "quickRatio": 2.263, "currentRatio": 2.325, "debtToEquity": 8.111, "returnOnAssets": -0.66110003, "returnOnEquity": -1.47334, "freeCashflow": -7551199, "operatingCashflow": -14595102, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746223756, "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 60354, "fiftyTwoWeekLowChange": 0.83500004, "fiftyTwoWeekLowChangePercent": 0.66269845, "fiftyTwoWeekRange": "1.26 - 2.71", "fiftyTwoWeekHighChange": -0.615, "fiftyTwoWeekHighChangePercent": -0.22693726, "fiftyTwoWeekChangePercent": -10.085839, "earningsTimestamp": 1742846400, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.76, "epsForward": -0.55, "epsCurrentYear": -0.68, "priceEpsCurrentYear": -3.0808823, "fiftyDayAverageChange": 0.38893998, "fiftyDayAverageChangePercent": 0.22797555, "twoHundredDayAverageChange": 0.22149003, "twoHundredDayAverageChangePercent": 0.11822196, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "postMarketChangePercent": -0.233889, "postMarketPrice": 2.0901, "postMarketChange": -0.00489998, "regularMarketChange": 0.045000076, "regularMarketDayRange": "2.0617 - 2.27", "marketState": "CLOSED", "regularMarketChangePercent": 2.1951256, "regularMarketPrice": 2.095, "displayName": "Immix Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]